<DOC>
	<DOC>NCT03073057</DOC>
	<brief_summary>The purpose of this study is to compare Budesonide/formoterol Easyhaler test products with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream.</brief_summary>
	<brief_title>Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler</brief_title>
	<detailed_description />
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Charcoal</mesh_term>
	<criteria>Written informed consent obtained Body mass index &gt; 19 and &lt; 30kg/m2, weight at least 50 kg Good general health ascertained by detailed medical history, and laboratory and physical examinations Evidence of a clinically significant cardiovascular, renal, hepatic, haematological, GI, pulmonary, metabolicendocrine, neurological or psychiatric disease Any condition requiring regular concomitant treatment (including vitamins and herbal products) or likely to need any concomitant treatment during a study. Known hypersensitivity to the active substance(s) or the excipient of the drug Pregnant and lactating females</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>